NCT05607901View on ClinicalTrials.gov

A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 28, 2022

Primary Completion Date

November 20, 2023

Study Completion Date

November 20, 2023

Conditions
Dermatologic Disease
Interventions
DRUG

Tacrolimus ointment

tacrolimus is an immunosuppressive drug acting as an immunomodulator to assist manage acute flares and reducing the severity of future flares

DRUG

Hydrocortisone 1% cream

Topical corticosteroids (TCS) are the cornerstone for the management of AD to which other treatments are compared.

Trial Locations (1)

31527

Tanta Unuversity, Tanta

All Listed Sponsors
lead

Tanta University

OTHER